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Abstract
Background: The adenosine/uridine-rich element (ARE)-binding protein AUF1 functions to regulate the
inflammatory response through the targeted degradation of cytokine and other mRNAs that contain specific AREs
in their 3’ noncoding region (3’ NCR). To investigate the role of AUF1 in the immune system, we characterized the
lymphoid compartments of AUF1-deficient mice.
Results: Mice lacking AUF1 exhibit an altered proportion and size of splenic B cell subsets. We show prominent
apoptosis in splenic B cell follicles and reduced expression of Bcl-2, A1, and Bcl-XL correlate with increased turnover
and significant reduction in the number and proportion of splenic FO B cells in AUF1-deficient mice. In addition,
AUF1-deficient mice exhibit a sharp decrease in splenic size and lymphocyte cellularity. Bone marrow transfer
studies demonstrate that AUF1 deficiency induces cell-autonomous defects in mature B cell subsets but not in the
overall number of splenocytes. Reconstitution of irradiated adult AUF1-deficient mice with wild-type bone marrow
restores the proportion of FO and marginal zone (MZ) B cells, but does not rescue the decrease in the number of
splenocytes. Functionally, AUF1-deficient mice mount an attenuated response to T cell-independent (TI) antigen,
which correlates with impaired MZ B cell function.
Conclusion: These data indicate that AUF1 is important in the maintenance of splenic FO B cells and adequate
humoral immune responses.
Background
The mammalian spleen functions to remove old and
damaged erythrocytes, participates in the immune
response, particularly against blood-borne pathogens,
and is the major site for peripheral B cell development
[1]. Immature surface immunoglobulin-expressing B
cells that reach the spleen from the bone marrow
(referred to as ‘transitional’ B cells) represent develop-
mental precursors to mature follicular (FO) B lympho-
cytes, the major mature B cell population in the spleen
[2,3]. The other two mature B cell populations consist
of non-circulating splenic marginal zone (MZ) B cells
that are believed to be derived from transitional cells,
and B-1 cells, that are controversial in origin and are
enriched in peritoneal and pleural cavities [4]. FO B
cells contribute to most T-cell dependent (TD)
responses that induce germinal center (GC) develop-
ment of affinity-matured long lived plasma cells and
memory B cells [4,5]. In contrast, MZ cells and B-1 cells
are predominately responsible for the initial rapid T-cell
independent (TI) IgM antibody response and form an
important line of defense against antigens and patho-
gens in the blood and mucosal sites [4,6]. More recent
analysis of B cell populations suggests that there exist
two distinguishable, long-lived, recirculating post-transi-
tional follicular B cell populations, the mature FO B cell
subset described above and a new subset referred to as
FO-II B cells. The FO-II B cells differ from FO B cells
in that they develop in an antigen-independent manner
and may serve as a follicular precursor to both MZ B
cells and FO B cells [7].
Although the precise mechanisms are still unclear,
maintenance of each peripheral B cell subset is affected
by the availability of resources, the local environment,
and interactions with other cell types [8]. It is known
that signaling through the B cell receptor (BCR) is
required for the development and maintenance of
mature splenic B cells [9]. Genetic studies utilizing
knockout mouse models for various BCR complex
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strate that an adequate BCR signal is indispensable for
the development of transitional B cells and further dif-
ferentiation into mature B cells [2,10-14]. Furthermore,
an ongoing or ‘tonic’ BCR signal is required for B cells
to survive [11,15]. This was elegantly shown using an
inducible disruption of the BCR in mature B cells,
which resulted in the absence of all three mature sub-
sets [16]. In addition to BCR signaling, both the splenic
microenvironment and the ability to respond to locally
produced growth factors play equally important roles in
the development and maintenance of mature B cells
[17,18].
Many short-lived mRNAs that encode cytokines and
cell survival factors contain an adenosine/uridine-rich
element (ARE) in the 3’ non-coding region that allows
for their post-transcriptional regulation by ARE-binding
proteins. AUF1, also known as heterogeneous nuclear
ribonucleoprotein D, is important in promoting the
decay of ARE-containing mRNAs [19-21]. In addition to
mRNA turnover, AUF1 has more recently been impli-
cated in a number of other cellular processes, including
mRNA translation [22] and chromatin remodeling [23].
The physiological role of AUF1 in controlling the decay
of key pro-inflammatory cytokine mRNAs, interleukin
(IL)-1b and tumor necrosis factor (TNF)-a, was demon-
strated by the increased sensitivity of AUF1
-/- mice to
endotoxic shock and lethality [20]. AUF1 also regulates
inflammation within the skin, and AUF1
-/- mice develop
atopic-like dermatitis [24].
Given the high expression of AUF1 in lymphoid
organs [25], we characterized the lymphoid compart-
ment of AUF1-deficient mice. Here we show that
AUF1
-/- mice develop spleens of reduced size that sup-
port a roughly two-fold reduction in the number of lym-
phocytes. FO B cells exhibit a two-fold decrease in
average half-life in AUF1
-/- mice that correlates with
reduced expression of Bcl-2, A1, and Bcl-XL,a sw e l la s
prominent apoptosis within splenic follicles. The
increased turnover of FO B cells corresponds to their
decreased frequency in AUF1
-/- mice. Our studies indi-
cate that AUF1 plays an important role in regulating
splenic lymphocyte cellularity and FO B cell
maintenance.
Methods
Mice
The AUF1
-/- mice were derived as previously described
[20]. RAG1
-/- mice (B6.129S7-Rag1
tm1Mom) and CD45.1
mice (B6.SJL-Ptprc
aPep3
b/BoyJ) were purchased from
Jackson Labs. For adoptive transfer studies, 5 × 10
6
donor-derived bone marrow cells were injected intrave-
nously into sub-lethally irradiated (500 rad) RAG1
-/- or
into lethally irradiated (950 rad) AUF1
+/+ and AUF1
-/-
recipient mice. Chimera mice were analyzed 10 weeks
post transfer. CD45 allele expression was used to distin-
guish donor and recipient populations. All mice are kept
under specific pathogen-free conditions. All animal pro-
tocols were approved by the NYU Institutional Animal
Care and Use Committee.
Flow Cytometry
Single cell suspensions were prepared from spleen, ingu-
inal and mesenteric lymph nodes, peritoneum lavage,
bone marrow, and thymus. Cells were stained and ana-
lyzed as previously described [20]. Cell sorting was per-
formed on a BD FACSVantage cell sorter. The following
Abs were used: from BD PharMingen: anti-B220-PerCP
(RA3-6B2), anti-CD3-PerCP (17A2), anti-CD4-FITC
(GK1.5), anti-CD8-APC (53-6.72), anti-IgM-FITC (R6-
60.2), anti-CD94-APC (18d3), Streptavidin-APC, Strep-
tavidin-FITC; from Caltag: anti-CD62L-PE (MEL-14),
anti-CD23-PE (B3B4); from eBioScience: anti-CD44-bio-
tin (IM7), anti-IgM-biotin (II/41), anti-CD5-FITC (53-
7.3), anti-CD24-PE (M1/69), anti-IgD-biotin (11-26),
anti-CD21/CD35-FITC,-APC (4E3), anti-F4/80-biotin
(BM8), anti-CD86-biotin (GL1), anti-CD45.1-biotin
(A20), and anti-CD45.2-biotin (104). Bcl-2 levels were
detected using the Bcl-2 kit (BD Pharmingen), following
manufacturer’s instructions. The set contains anti-Bcl-2-
PE (3F11) and PE-conjugated isotype control.
Immunohistochemistry
Hematoxylin and eosin stained sections were processed
as previously described [20]. Germinal center staining
was performed at 8 and 22 days post-immunization with
TNP-Ficoll and TNP-KLH, respectively. The reagents
used were from eBioscience: anti-mouse B220 (RA3-
6B2); Cell Signaling: rabbit anti-cleaved caspase-3 (5A1);
BD Pharmigen: CR1 (8C12); Vector Laboratory: biotiny-
lated peanut agglutinin, biotinylated anti-rabbit IgG,
Vectastain ABC-AP, Vectastain ABC, Vector blue AP
kit, and Vector NovaRED peroxidase kit.
BrdU labeling
Mice were injected intraperitoneally with 1 mg of BrdU
(Sigma-Aldrich) and fed with drinking water containing
1 mg/ml BrdU for 7 days. At 0, 7, and 21 days post
BrdU administration, spleens from 3 mice per group
were analyzed by FACS. Cells were stained with anti-
CD21-FITC and anti-CD24-PE or anti-CD23-PE, and
then were fixed for 16 h at 4°C with 3.4% paraformalde-
hyde and 0.01% Tween-20 in PBS. Cells were washed,
incubated for 30 min at 37°C with 5 mM MgCl2,1 %
BSA, and DNase I (100U) in PBS, then labeled with bio-
tinylated anti-BrdU (Br-3, Caltag) or biotinylated anti-
IgG control (eBioscience), and subsequently stained with
Streptavidin-APC. The mean BrdU labeling at 7 days
was used to calculate the labeling rate per day; 2.5% and
1.5% per day in KO and WT mice, respectively. To cal-
culate average life span, the mean values were plotted as
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sion analysis was performed to calculate time to lose the
BrdU labeled population, assuming a constant pool size
during the analysis.
B cell isolation, Ca
2+ mobilization response, in vitro
proliferation and survival assays
Splenic B cells were purified with the MACS CD45R
microbead system and were verified by FACS to be ≥
98% B220
+. Splenic B cells or sorted MZ B cells were
loaded with 2 μM Fluo-4/AM (Molecular Probes), sti-
mulated with 10 μg/ml F(ab’)2 goat anti-IgM Ab and
Ca
2+ mobilization was recorded on live gated cells. For
proliferation assays, 2 × 10
4 MZ B cells were plated in
triplicate in 96 well plates and stimulated with 10 μg/ml
F(ab’)2 goat anti-IgM Ab or with 10 μg/ml LPS. For the
last 8 h of the 48 h culture period the cultures were
pulsed with 1 μCi/well [
3H]-thymidine. Incorporated
radioactivity was quantified by scintillation counting.
For CD86 up-regulation studies, CD86 expression was
analyzed by flow cytometry before and after 24 h treat-
ment with F(ab’)2 goat anti-IgM Ab (10 μg/ml). For cell
viability assays, sorted FO B cells were cultured as stated
and then analyzed by flow cytometry after the addition
of 7-amino-actinomycin (7-AAD) (5 μg/ml).
Quantitative real-time RT-PCR
FACS-sorted splenic B220
+CD21
intCD24
lo FO B cells
were homogenized in Trizol (Invitrogen) and mRNA
was extracted according to manufacturer’s instructions.
Bcl-2, A1, and Bcl-XL mRNA levels were determined
using the Roche LightCycler system. CT values were
used to calculate relative values and were normalized to
CT values for cyclophilin A. The following primer pairs
were used:
Bcl-2, CCTGTGGATGACTGAGTACC and
GAGACAGCCAGGAGAAAT
A1, CTTCAGTATGTGCTACAGGTACCCG and
TGGAAACTTGTTTGTAAGCACGTCCAT
Bcl-XL, AGAAGAAACTGAAGCAGAG and
TCCGACTCACCAATACCTGCGTCCAT
BAFF, CTGTGGTCACTTACTCCAAAGG and
GGATCAGATTCAACGGGTCACG
BAFF-R, GCCCAGACTCGGAACTGTCCCA and
GCCCAGTAGAGATCCCTGGGTTCC
CypA, TATCTGCACTGCTAAGACTGAATG and
CTTCTTGCTGGTCTTGCCATTCC.
Immunoblot analysis
Immunoblot analysis was performed according to stan-
dard protocols using ECL detection (PerkinElmer). Poly-
clonal antibodies to AUF1 (995) and to eIF4E (Sigma)
were used.
Humoral response assay
Total pre-immune serum and TNP-specific titers were
determined using the SBA Clonotyping ELISA kit from
SouthernBiotech according to manufacturer instructions.
To evaluate TI-II responses, mice were immunized with
10 μg TNP-Ficoll (Biosearch Technologies) and bled 7
days post immunization. To evaluate TD responses,
mice were immunized with 20 μg TNP-KLH (Biosearch
Technologies) with adjuvant (Imject Alum, Pierce) and
bled 14 days post immunization. For in vitro studies,
10
6 purified B cells were stimulated with murine IL-4
(20 ng/ml) and LPS (25 μg/ml) for 96 h. Immunoglobu-
lin secretion in the supernatant was measured as
described in immunization studies. RT-PCR looking for
post-switch transcripts was performed as previously
described [26].
Statistical analysis
Data are presented as mean ± standard deviation. For
statistical comparison of two samples, the two-tailed
Student t-test was used for evaluation.
Results
Reduction of FO B cells in spleens of AUF1-deficient mice
AUF1
-/- mice were found to have 1.5-fold smaller spleens
(71.3 ± 9.4 vs. 52.6 ± 3.1 mg) and a roughly two-fold
reduction in the number of splenocytes as compared to
wild-type controls (Table 1). Splenocyte reduction was
restricted to B and T lymphocytes, as the number of F4/
80
+ macrophages, CD94
+CD3
- natural killer, and CD16/
32
+B220
- cell populations in the spleens of AUF1
-/- mice
were unaffected (Table 1). Except for a decrease in
mature IgM
loIgD
hi Bc e l l s ,A U F 1
-/- mice exhibited no
significant differences in the cell populations of inguinal
and mesenteric lymph nodes, thymus, bone marrow or
peritoneal cells (Figure 1a; Table 1), as compared to
wild-type littermates. The unaltered cell subpopulations
of the bone marrow and thymus in AUF1
-/- mice suggest
that the reduction in splenocytes in these mice occurred
at the periphery within the spleen rather than during
development.
We therefore determined whether the splenocyte loss
was restricted to a defined lymphocyte population. The
different immature and mature splenic B cell subsets
were identified based on the expression of multiple
surface markers: CD21, CD23, CD24, IgM, and IgD
(Figure 1a) [3]. The analyses presented were performed
on mice 11-16 weeks of age, however, older mice ana-
lyzed (6 to 9 months of age) showed similar findings to
younger mice. This analysis showed that the sharp
reduction in splenic B lymphocytes was due predomi-
nately to a two-fold reduction in the number of FO B
cells (Figure 2). The absolute numbers of transitional
(immature) and MZ B cells were unchanged in AUF1
-/-
mice (Figure 2). Furthermore, analysis of post-transi-
tional precursor subsets, MZ precursor (MZP) B cells
and FO-II B cells, showed no differences in absolute
numbers (Figure 1b, Table 1). As a result of the
decrease in total splenocytes, there was an increase in
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28.0%) and MZ B cells (from 9.6% to 18.4%) whereas, in
contrast, there was a decrease in the proportion of
mature FO B cells (from 69.3% to 55.4%). As expected
with a decrease in splenic FO B cells, there was a
decrease in recirculating mature IgM
loIgD
hi Bc e l l si n
the bone marrow and lymph node of AUF1-deficient
mice (Figure 1a). An analysis of the third mature B cell
population, CD5
hiIgM
hi B-1 cells in the peritoneum,
showed no differences between wild type and AUFI
-/-
animals (Figure 1a). All surface markers analyzed were
expressed normally in AUF1-deficient splenic B cells,
with the exception of CD23, which exhibited reduced
expression (Figure 1c). Flow cytometric analysis of CD4,
CD8, CD44, and CD62L surface markers of T cells in
the spleen showed no differences (Figure 1a), suggesting
that the nearly two-fold reduction in splenic T cells was
not restricted to a defined T cell population.
Given the specific loss of FO B cells, we examined the
expression of AUF1 in different B cell subsets. Surpris-
ingly, flow cytometric analysis demonstrated that AUF1
expression was greatest in wild type MZ and T2 B cells,
two populations whose absolute numbers were unaf-
fected in AUF1
-/- mice (Figure 1d). AUF1 consists of a
family of four protein isoforms that are translated from
an alternatively spliced mRNA [27]. Thus, we sorted B
cell subsets and then analyzed AUF1 expression by
immunoblot analysis to examine individual isoform
expression. Consistent with the flow cytometery results,
immunoblot analysis demonstrated that AUF1 was most
strongly expressed in T2 B cells and MZ B cells. Differ-
ences in isoform expression were evident with T2 B
cells exhibiting a relative increase in the expression of
the p45 isoform. Surprisingly, FO B cells, which were
significantly reduced in AUF1-deficient mice, expressed
AUF1 at lower levels than other B cell subsets. These
findings suggest that a FO B cell-independent process
may be responsible for increased loss, such as through
regulation of survival factors. Nevertheless, we cannot
exclude the possible importance of an altered ratio of
AUFI isoform expression, as previously suggested [28].
Loss of FO B cells is due to absence of AUF1 expression
in the hematopoietic lineage
To determine whether the differences observed in sple-
nic B cell subsets in AUF1
-/- mice were dependent on
the expression of AUF1 in hematopoeitic cells, we per-
formed bone marrow adoptive transfer studies. An equal
number of bone marrow cells from AUF1-deficient or
w i l d - t y p em i c ew e r et r a n s f e r r ed into sub-lethally irra-
diated RAG1
-/- mice, which are devoid of mature B and
T lymphocytes. Ten weeks after cell transfer, the
RAG1
-/- recipient mice of AUF1
-/- bone marrow, similar
to AUF1
-/- mice, exhibited a greater than two-fold
reduction in number of splenic FO B cells and a sharp
Table 1 Splenocyte subpopulations in AUF1
+/+, AUF1
-/- and chimeric mice.
AUF1
+/+
(n = 10)
AUF1
-/-
(n = 10)
WTÆRAG1
-/-
(n =4 )
KOÆRAG1
-/-
(n =4 )
WTÆKO
(n =4 )
KOÆWT
(n =4 )
Total splenocytes 70.8 ± 10.7 41.6 ± 7.6 34.8 ± 3.6 24.7 ± 3.8 47.3 ± 4.1 73.6 ± 7.9
B220
+ 37.5 ± 3.3 23.4 ± 1.5 16.6 ± 0.9 10.6 ± 1.4 24.3 ± 6.2 39.7 ± 4.3
IgM
lo, IgD
hi (FO) 26.0 ± 2.3 (69.3) 13.1 ± 0.8 (55.3) 11.6 ± 0.1 (69.6) 5.3 ± 0.7 (50.0) 16.7 ± 0.6 (68.8) 21.0 ± 1.7 (53.0)
IgM
hi, IgD
hi (T2) 4.6 ± 0.9 (12.3) 4.3 ± 0.5 (18.2) 1.5 ± 0.3 (9.3) 1.6 ± 0.5 (14.6) 3.1 ± 0.9 (12.8) 8.2 ± 0.2 (20.7)
IgM
hi, IgD
lo (T1) 3.1 ± 0.5 (8.3) 2.4 ± 0.3 (9.8) 0.9 ± 0.2 (5.2) 1.1 ± 0.1 (10.5) 1.3 ± 0.1 (5.2) 3.9 ± 1.1 (9.9)
CD21
hiCD23
lo (MZB) 3.6 ± 0.6 (9.6) 4.3 ± 0.5 (18.4) 2.2 ± 0.2 (13.2) 2.7 ± 0.3 (25.7) 1.6 ± 0.4 (6.6) 5.2 ± 1.2 (13.1)
CD21
intCD23
hi (FO) 29.8 ± 0.8 (79.5) 13.2 ± 2.7 (59.1) 11.6 ± 1.9 (70.0) 5.5 ± 0.9 (52.0) 20.6 ± 0.2 (84.9) 23.9 ± 1.3 (60.2)
CD21
loCD23
lo (NF) 3.4 ± 0.7 (9.1) 3.9 ± 2.6 (17.5) 2.5 ± 0.2 (15.1) 2.2 ± 0.9 (20.5) 1.9 ± 0.5 (7.8) 10.0 ± 0.1 (25.3)
IgM
hiIgD
loCD21
lo (NF) 2.0 ± 0.3 (5.2) 2.3 ± 0.3 (8.0) ND ND ND ND
IgM
hiIgD
hiCD21
int (FOII) 3.4 ± 0.6 (9.1) 3.6 ± 0.8 (13.1) ND ND ND ND
IgM
loIgD
hiCD21
int (FO) 24.3 ± 2.4 (66.0) 14.6 ± 2.0 (53.0) ND ND ND ND
IgM
hiIgD
hiCD21
hi (MZP) 1.7 ± 0.4 (4.5) 1.5 ± 0.3 (5.5) ND ND ND ND
IgM
hiIgD
loCD21
hi (MZ) 4.4 ± 0.8 (11.2) 4.7 ± 0.5 (16.2) ND ND ND ND
CD3
+
F4/80
+
21.3 ± 1.4
0.9 ± 0.1
13.8 ± 0.6
0.9 ± 0.1
15.0 ± 0.7
2.1 ± 1.4
10.4 ± 0.5
3.0 ± 0.7
15.8 ± 1.2
1.1 ± 0.3
23.6 ± 3.3
1.0 ± 0.2
CD94
+CD3- 1.0 ± 0.3 1.0 ± 0.1 ND ND ND ND
CD16/CD32
+B220
- 4.3 ± 1.3 4.4 ± 1.1 ND ND ND ND
Cell numbers are stated at × 10
6. Values represent the mean ± SD. For B cell subsets, the percentage of each subset in B220
+ gated cells is given in parenthesis.
AUF1-deficient and wild-type mice used for this analysis were 11-16 weeks of age. ND; not determined.
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Figure 1 Flow cytometric analysis of lymphocyte populations in AUF1
-/- mice. (a) Single cell suspensions from spleen (SP), bone marrow
(BM), lymph node (LN), peritoneal cavity (PerC), and thymus (Thy) of AUF1
-/- (KO) and wild-type (WT) littermates were stained with the indicated
antibodies and analyzed. Numbers indicate the percentage of lymphoid cells in quadrants or enclosed within indicated gates. Contour plots
gated for B220
+ or CD3
+ lymphocytes are indicated. Note decrease in FO B cells in AUF1
-/- spleens as represented by IgD
hiIgM
lo, CD21
intCD24
lo,
or CD21
intCD23
hi gates. There is also an increase in the proportion of MZ B cells in KO spleens as represented by CD21
hiCD23
lo gate. (b) Splenic
B cells were analyzed for IgD and IgM expression (left panels) and gated populations were then analyzed for CD21 expression (right panels). This
analysis distinguishes five different splenic populations (from left to right): NF, IgM
highIgD
lowCD21
low; MZ, IgM
highIgD
lowCD21
high; FO-II,
IgM
highIgD
highCD21
int; MZP, IgM
highIgD
highCD21
high; and FO-I, IgM
lowIgD
highCD21
int. Three mice were analyzed in each group. (c) Decreased CD23
expression in AUF1
-/- B cells (B220
+) and FO B cells (IgM
loIgD
hi) from AUF1
-/- mice. (d) AUF1 expression in B cell subsets as determined by FACS
(left panels) or immunoblot analysis (right panels). In immunoblot analysis, the staining with AUF1 shows three bands corresponding to the four
isoforms of AUF1, and level of eIF4E is shown as a control. Numbers in parenthesis in (c) and (d) depict mean fluorescence intensity (MFI).
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Figure 2 Splenic B cell populations in AUF1-deficient mice. Cell populations were determined on the basis of total cell counts and flow
cytometric analysis shown in Figure 1. Data are mean ± SD from experiments using eight mice per group. * p < 0.01.
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Page 5 of 14decrease in the proportion of FO B cells (from 69.6% to
50.0%) as compared to RAG1
-/- recipient mice of wild-
type bone marrow (Figure 3a, Table 1). Similarly, irra-
diated wild-type mice reconstituted with AUF1
-/- bone
marrow exhibited a reduction in the proportion of FO B
cells (from 68.8% to 53.0%) as compared to irradiated
AUF1
-/- mice reconstituted with wild-type bone
marrow (Figure 3a, Table 1). Irradiated RAG1
-/- or wild-
type recipients of AUF1
-/- bone marrow, similar to
AUF1
-/- mice, showed a reduction in CD23 expression
(Figure 3b). These data demonstrate that changes in the
frequency of mature B cells and decreased CD23 expres-
sion in AUF1
-/- mice are intrinsic to the hematopoeitic
lineage.
Decreased number of splenocytes in adult AUF1
-/- mice is
not rescued by transfer of wild-type bone marrow
AUF1
-/- mice have much smaller spleens that support
roughly half the number of splenocytes as compared to
wild-type littermates (Figure 4; 70.8 ± 10.7 vs 41.6 ±
7.6 × 10
6). To investigate if the decreased cellularity was
dependent on AUF1 expression in the hematopoeitic
population, bone marrow adoptive transfer experiments
Figure 3 Flow cytometric analysis of lymphocyte populations in bone marrow chimeric mice. (a) Ten weeks post bone marrow
transplantation, splenocytes from indicated bone marrow chimeric mice were stained with the indicated antibodies and analyzed. Numbers
indicate the percentage of lymphoid cells in quadrants or enclosed within indicated gates. Contour plots gated for B220
+ are indicated. FO B
cells are represented by IgD
hiIgM
lo, CD21
intCD24
lo, and CD21
intCD23
hi gates and MZ B cells are represented by the CD21
hiCD23
lo gate.
Splenocytes in bone marrow chimeras are of donor origin as shown by CD45 analysis. (b) Decreased CD23 expression in B cells (B220
+) and FO
B cells (IgM
loIgD
hi gated) from chimeric mice receiving bone marrow from AUF1
-/- donors. Numbers in parenthesis indicate the MFI of CD23
expression.
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Page 6 of 14were performed. Surprisingly, irradiation of adult
AUF1
-/- mice and reconstitution with wild-type bone
marrow did not rescue the reduction in splenic lympho-
cyte cellularity (Figure 4). Most simply these adoptive
transfer studies suggest that the signals required for
determining the number of splenic lymphocytes is likely
provided by radiation-resistant stromal cells. However,
we cannot rule out the possibility that these signals may
be provided by the hematopoeitic lineage in a develop-
mentally-fixed manner, similar to the mechanism
described for the lymphotoxin signal needed in proper
splenic organization [29,30]. Thus, these bone marrow
transfer studies suggest that AUF1 influences two sepa-
rate processes, since the transfer of wild-type bone mar-
row cells into AUF1
-/- recipients corrects the proportion
of FO and MZ B cells, but does not rescue the
decreased number of splenocytes (Figure 4; Table 1).
Similarly, transfer of AUF1
-/- bone marrow cells into
wild-type recipients results in a decreased proportion of
FO B cells and increased proportion of MZ B cells, but
does not alter the absolute number of splenocytes.
Thus, we favor the hypothesis that AUF1 influences two
separate processes: maintenance of the proportion of
specific subsets of the mature B cell population. A func-
tion that is autonomous to AUF1 expression; and influ-
encing the overall number of splenocytes, which is not
autonomous to AUF1 expression in the hematopoeitic
lineage.
Increased turnover of FO B cells in AUF1-deficient mice
Mutations affecting either the production or survival of
mature B cells can influence the number of B cells in
the spleen [31]. Therefore, we next addressed whether
the decrease in FO B cells in AUF1
-/- mice results from
a defect in cell production and/or survival. Examination
of B cell follicles in the spleens of AUF1-deficient mice
revealed many pyknotic and fragmented cells character-
istic of cells undergoing apoptosis (Figure 5a). The
striking increase in the presence of apoptotic cells
within the splenic follicles of AUF1
-/- mice was con-
firmed by cleaved caspase-3 staining (Figure 5a). Simi-
larly, RAG1
-/- mice reconstituted with AUF1
-/- bone
marrow exhibited pronounced apoptosis in splenic folli-
cles (Figure 5b), a finding not seen in RAG1
-/- mice
reconstituted with wild-type bone marrow. BrdU pulse-
chase studies were performed to directly measure the
turnover of FO B cells. Mice were continuously fed
BrdU for 7 days and the proportion of BrdU-positive
splenic FO B cells (B220
+CD21
loCD24
hi)w a sd e t e r -
mined by flow cytometery at 0, 7, or 14 days following
BrdU administration. At the end of the pulse period, a
significantly greater proportion of FO B cells were
labeled in AUF1
-/- mice as compared to wild-type litter-
mates (Figure 5c). The percentage of BrdU
+ FO B cells
stayed fairly stable for wild-type control mice during the
chase period, but noticeably declined in AUF1
-/- mice
( F i g u r e5 c ) ,d e m o n s t r a t i n gat w o - f o l dd e c r e a s ei nt h e
average half-life of AUF1
-/- B cells (from 68 to 32 days).
In contrast, BrdU pulse-chase studies demonstrated no
differences in the labeling or turnover of MZ B cells in
AUF1
-/- m i c e( F i g u r e5 c ) .I ti sw e l l - e s t a b l i s h e dt h a tt h e
expression of Bcl-2 anti-apoptotic and pro-apoptotic
family members is vital for the maintenance of B cells
within the spleen [32]. Therefore, we assessed the levels
of Bcl-2, A1, Bcl-XL, and BIM mRNA in freshly sorted
FO B cells from AUF1
-/- and wild-type mice. AUF1-defi-
cient FO B cells exhibited a significant decrease in all
three anti-apoptotic factors (Figure 5d), with a 40%
r e d u c t i o ni ne x p r e s s i o no fB c l - 2a n dB c l - X L mRNAs
and 65% reduction in A1 mRNA levels. However, no
significant difference was seen in BIM mRNA levels in
FO B cells from AUF1
/- and wild-type mice. We further
validated these results by comparing Bcl-2 protein levels
in mature splenic B cell populations of AUF1
-/- mice by
flow cytometry. This analysis was restricted to Bcl-2
because it was not possible to measure A1 by flow cyto-
metry. Consistent with a 40% decrease in Bcl-2 mRNA
expression, the level of Bcl-2 protein expression was
similarly decreased in FO B cells from AUF1
-/- mice
(Figure 5e). In contrast, MZ B cells from AUF1
-/- mice
exhibited no difference in Bcl-2 expression as compared
to MZ B cells from wild-type littermates (Figure 5e-f).
We further characterized FO B cell turnover, by analyz-
ing cell death in cultured cells via 7-AAD analysis. We
purified FO B cells based on CD24 and CD21 markers,
because purification with IgM and IgD could elicit BCR
signals that influence B cell survival. FO B (CD21
intC-
D24
lo) cells lacking AUF1 were more susceptible to
spontaneous cell death in the first 36 hours in culture
(Figure 5f). CD40 engagement has been shown to be
important in the up-regulation of Bcl-2 family members
0
25
50
75
100 * *
Number of splenoc
ytes (x10  )
6
KO WT KO KO WT WT
Figure 4 Number of splenocytes in AUF1
-/- mice and bone
marrow chimeras. Each point represents cell counts from a single
mouse as determined by hemocytometry. * p < 0.05.
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Page 7 of 14[33]. Thus, FO B cells were stimulated in culture by
CD40 engagement to assess the ability to express Bcl-2
family members. AUF1-deficient FO B cells showed no
differences in viability or in ability to express anti-apop-
totic Bcl-2 family members upon CD40 engagement
(Figure 5g). These data indicate that AUF1 deficiency
leads to a decrease in FO B cell survival, presumably by
impairing the expression of key survival factors Bcl-2,
Bcl-XL, and A1 in absence of CD40 engagement.
No defect in BCR signaling, in vitro maturation,
or BAFF-R expression in AUF1
-/- B cells
To directly determine whether AUF1 plays a role in the
development of FO B cells, we assayed the in vitro
maturation of T2 B to FO B cells, as previously described
[9]. BCR engagement on T2 B cells drives their differen-
tiation to a mature B cell phenotype, as characterized by
down-regulation of CD21 and CD24 surface expression.
B220
+CD21
hiCD24
hi T2 splenocytes were sorted and
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Figure 5 Prominent apoptosis, increased turnover, and decreased expression of Bcl-2, A1, and Bcl-XL in AUF1-deficient FO B cells. (a-b)
Prominent apoptosis (arrows) seen in splenic B cell follicles from (a) AUF1
-/- and (b) irradiated RAG1
-/- mice reconstituted with AUF1
-/- bone
marrow. Apoptosis was confirmed by cleaved caspase-3 staining. Scale bar = 0.1 mm. (c) Analysis of in vivo B cell turnover. Mice were fed BrdU
for 7d, and incorporated BrdU was determined by flow cytometric analysis. The percentage of BrdU-positive FO (CD21
intCD24
lo)o rM Z
(CD21
hiCD23
lo) B cells from the spleens of wild-type (white) and AUF1
-/- (black) mice was plotted; n = 3 per time point. (d) Relative Bcl-2, A1, Bcl-
XL, BIM mRNA levels in sorted FO B cells from AUF1
-/- and wild-type mice were determined by qRT-PCR. Values were normalized to cyclophilin
levels and depicted as mean ± SD, n = 4. (e) Four-color flow cytometric analysis was performed to identify intracellular Bcl-2 protein levels in FO
and MZ B cells. Histograms depict the intensity of wild-type (bold) and AUF1
-/- (shaded) cells stained with Bcl-2 antibody or wild-type stained
with isotype-matched control antibody (thin line). Quantification of Bcl-2 expression. The normalized values (MFI for Bcl-2 - MFI of isotype-
matched control) for AUF1
-/- cells (FOB 11.9, MZB 9.6) were plotted as a percentage of wild-type values (FOB 16.9, MZB 9.0). Graph represents
mean ± SD, n = 4. * p < 0.05. (f-g) Sorted FO B cells were cultured in media alone or with anti-CD40 (10 μg/ml) for times indicated and (f) the
percent of live cells was determined by 7-AAD exclusion or (g) Bcl-2 and A1 mRNA levels were determined 24 hrs post culture. Values represent
means ± SD for three to four mice in each group.
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Page 8 of 14cultured in the presence or absence of BCR stimulation
and analyzed after 48 h (Figure 6a-b). Consistent with the
BrdU studies, AUF1
-/- T2 B cells exhibited no defect in
maturation to a mature B cell phenotype in vitro
(Figure 6b), suggesting that the BCR signaling pathway
mediating this transition is unaffected by the absence of
AUF1. AUF1
-/- B cells showed no differences in the dura-
tion or amplitude of Ca
2+ flux (Figure 6c), cell size
increase (data not shown), and up-regulation of the acti-
vation marker CD86 (Figure 6d) post-BCR ligation, as
compared to wild-type B cells. These results therefore
indicate that the proximal events of BCR-mediated sig-
naling, shown to be vital in B cell maturation and survival
[13,16], are unaffected in AUF1
-/- B cells. BAFF, a mem-
ber of the TNF superfamily, and its major receptor
BAFF-R have been shown to be critical in supporting
transitional B cell maturation and enhancing the survival
of mature B cells [34,35]. No differences were observed
in the mRNA levels of BAFF-R in sorted FO AUF1
-/- B
cells or in BAFF mRNA in AUF1
-/- spleens as compared
to wild-type controls (Figure 6e).
Decreased T cell-independent humoral response
in AUF1
-/- mice
To determine the functional consequence of AUF1 defi-
ciency, we next measured the ability of AUF1
-/- mice to
mount a normal humoral immune response to antigenic
challenge. TI antigen, TNP-Ficoll, or TD antigen, TNP-
KLH, was injected intraperitoneally into AUF1
-/- and
wild-type mice. Serum levels of TNP-specific antibodies
were measured 7 and 14 days post-immunization with
TNP-Ficoll and TNP-KLH, respectively. In the absence
of antigenic challenge, we observed no differences in
basal serum Ig levels between AUF1
-/- and wild-type
mice (Figure 7a, 7c). Consistent with this finding, we
observed no differences in architecture or number of
germinal centers (Figure 7a, 7d) or follicular dendritic
network (Figure 7b) in spleens of AUF1
-/- mice. How-
ever, AUF1
-/- spleens showed distortion of distinct B
Figure 6 Normal in vitro maturation and BCR signaling in AUF1-deficient B cells. (a) Sorted T2 B cells (B220
+CD21
hiCD24
hi) were cultured
with (+) or without (-) F(ab’)2 anti-IgM (10 μg/ml) for 48 h, and then analyzed by flow cytometry for CD21 and CD24 expression. (b) The
percentage of live cells falling into T2 (CD21
hiCD24
hi) and FO (CD21
intCD24
lo) gates are shown; mean ± SD, n = 3. (c) Calcium flux analysis in
response to BCR cross-linking. Arrow indicates time at which anti-IgM (10 μg/ml) was added to cells. (d) CD86 upregulation in B cells with (gray)
or without (white) stimulation with F(ab’)2 anti-IgM. Data in (c-d) is representative of three independent experiments. (e) mRNA levels of BAFF-R
in sorted FO B cells (left panel) and BAFF in splenocytes (right panel) as determined by qRT-PCR.
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Page 9 of 14and T cell zones, as B cells are seen in PALS, a T cell
area largely devoid of B cells in spleens from wild-type
mice (Figure 7b). AUF1
-/- mice mounted a robust TD
humoral response to immunization with TNP-KLH,
consistent with the presence of very large germinal cen-
ters in the center of B cell follicles, where T cells nor-
mally reside (Figure 7d). Given the decrease in the
number of FO B cells, one might have expected attenua-
tion rather than augmentation of the TD humoral
response. This discrepancy may stem from organiza-
tional defects that lead to aberrant germinal centers in
the PALS in AUF1
-/- mice. It may also reflect the
increased T cell response as a result of aberrant control
of IL-2 in AUF1
-/- mice [36]. In contrast, AUF1
-/- mice
showed a decreased humoral response to a TI antigen,
TNP-Ficoll (Figure 7a). Given the importance of MZ B
cells in an effective TI humoral response [37], we can-
not rule out that AUF1 is important for proper MZ B
cell function, especially given the high relative expres-
sion of AUF1 in this population (Figure 1d). This is sup-
ported by attenuation of cell size increase and
attenuated proliferative response to BCR-ligation and
LPS in AUF1-deficient MZ B cells as compared to wild-
type controls (Figure 7e-f). There was no difference in
calcium flux post-BCR ligation in MZB cells (Figure 7g),
which suggests that the impact of AUF1 on MZ B cell
function is downstream of calcium mobilization.
It has been suggested that as part of the LR1 transcrip-
tion complex, AUF1 may play a role in heavy chain class
switch recombination (CSR) [38]. Isotype CSR requires
the transcription of class-specific mRNAs [39]. RT-PCR
directed at amplifying post-switch targets composed of
the Iμ exon spliced onto the 5’ exon of the Cg1 and Cg2b
gene, loci reported to bind LR1 with the highest affinity
[40], was performed on purified cultured B cells 4 days
post-activation. AUF1
-/- B cells did not display any defect
in class-specific transcripts (Figure 7h). Furthermore,
AUF1
-/- B cells cultured in the presence of IL-4 and
either LPS or an antibody to CD40 exhibited no defect in
the in vitro production of serum Igs (Figure 7i), indicat-
ing that AUF1 does not play a direct role in CSR activity
in B cells. However, we cannot rule out that AUF1 may
play an indirect role in proper humoral responses in vivo
Figure 7 Impaired T-cell independent humoral response in AUF1
-/- mice. (a) Total serum immunoglobulin levels in naïve mice. Each point
represents the value obtained from an individual mouse, AUF1
-/- (black) or wild-type (white); n = 6. Naïve spleens were stained for B cells (B220)
and germinal centers (PNA). (b) B cell follicles were visualized by antibody to B220 and arrows indicate splenic arterioles. Follicular dendritic cells
were visualized by antibody to CR1. Scale bar = 0.1 mm. (c) Serum immunoglobulin (Ig) levels in naïve mice (preimmune, PI), and in mice post
immunization with TNP-Ficoll (TI-II) or TNP-KLH (TD). Each point represents the value obtained from an individual mouse, AUF1
-/- (black) or wild-
type (white); n = 5, * p < 0.05. (d) Spleen sections from immunized wild-type and AUF1
-/- mice were stained for B cells with anti-B220 (brown)
and peanut agglutinin (PNA; blue) to visualize germinal centers (GCs, arrows). Scale bar = 0.5 mm. Numbers of GCs per lower power field (LPF,
10×) were quantified. Values represent means from 5 mice (5 fields per mouse) ± SD. (e) Median cell size and (f) proliferation response to anti-
IgM (10 μg/ml) or LPS (10 μg/ml) in sorted MZ B cells. Plots represent mean ± SD, n = 3; * p < 0.05. (g) Calcium flux analysis in response to BCR
cross-linking. Arrow indicates time at which anti-IgM (10 μg/ml) was added to cells. Data is representative of three independent experiments.
(h) RT-PCR directed at amplifying post-switch targets composed of Iμ exon spliced onto the 5’ exon of Cg1 and Cg2b gene or b-actin gene
control performed on B cells stimulated with LPS + IL-4 for 4 days. (i) Total secreted immunoglobulin (Ig) levels or indicated isotypes in culture
supernatants from B cells stimulated with LPS + IL-4 or anti-CD40 + IL-4 for 4 days as determined by ELISA.
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and immunoglobulin production.
Discussion
Our results show that AUF1 deficiency leads to a distur-
bance in mature splenic B cell populations and in
humoral immune responses. Past studies of mice with
defective BCR signaling have demonstrated that the
strength of the BCR signal is important in both matura-
tion and determination of the cell-fate of the immature
B cells [2,11,15]. Furthermore, these studies collectively
indicate that weak BCR signals favor MZ B cell develop-
ment, whereas relatively strong signals favor the devel-
opment of FO B cells, and perhaps even stronger signals
favor the generation of B1 cells [11]. Our results indi-
cate that the reduction of B cell numbers is specific to
FO B cells, as normal numbers of T1, T2, FO-II, MZP,
and MZ B cells are seen in spleens of AUF1
-/- mice, as
well as in irradiated RAG1
-/- mice reconstituted with
AUF1
-/- bone marrow. These data suggest that there is
no developmental block, nor are transitional B cells
diverted to the mature MZ B cell population at the
expense of FO B cells, in contrast to mice with impaired
BCR signaling [11]. In agreement with this hypothesis,
there is no impairment in production of FO B cells
in vitro as shown by maturation assays, or in vivo as
demonstrated by BrdU labeling studies. Overall, we con-
clude that development of FO B cells is unaffected in
AUF1
-/- mice. In addition to its role in development,
signals processed by the BCR complex are required for
mature B cells to survive in the periphery. The specific
loss of FO B cells in AUF1
-/- mice does not seem to
result from abnormal BCR signaling, as downstream
events of BCR engagement, such as calcium mobiliza-
tion are unaffected in AUF1
-/- B cells.
The phenotype seen in AUF1
-/- mice does not seem to
involve BAFF signaling, which has been shown to be
important in both B cell development and homeostasis
[34,35]. BAFF, a member of the TNF superfamily, and
its receptors, BR3 and TACI, are not encoded by
ARE-mRNAs and are therefore unlikely to be direct
targets of AUF1. As predicted, no difference was
observed in the expression of BAFF or its receptor in
AUF1-deficient mice. Furthermore, the phenotype of
BAFF-deficient mice differs from that of AUF1
-/- mice.
BAFF-deficient mice exhibit a loss of both MZ and FO B
cells, as well as severely reduced antibody titers in response
to both TD and TI antigens [34,41]. In contrast, AUF1
-/-
mice exhibit a selective loss of the FO B cell subset and a
moderate attenuation of the TI humoral response. BAFF
signaling is important in CD21 expression in B cells inde-
pendent of its role in cell survival [41], and its regulation of
CD23 expression is less clear. There are conflicting reports
on the role of BAFF on CD23 expression from BAFF-
deficient, BAFF-R-deficient, and transgenic BAFF mice
[41-43]. In contrast, AUF1-deficient B cells show normal
CD21 surface expression, but exhibit a reduction in CD23
surface expression (Figure 1). Although direct functions of
AUF1 cannot be ruled out, alterations in local factors such
as interleukin-4 in part may explain the decrease in CD23
expression in AUF1
-/- Bc e l l s[ 4 4 ] .C D 2 3e x p r e s s i o no nB
cells is involved in antigen presentation and IgE response,
as demonstrated by the enhanced IgE response elicited in
CD23-deficent mice [45]. We have previously shown that
AUF1
-/- mice have increased circulating IgE levels [36] that
m a yb ed u et ot h er e d u c e dC D 23 expression on AUF1-
deficient B cells.
In the periphery, a lymphocyte acquires survival sig-
nals through receptors for cytokines, antigens, and hor-
mones [8,46]. Failure to adequately acquire such signals
results in cell death and thus determines the size of the
peripheral lymphocyte pools [8,46,47]. Although signal-
ing through the BCR is required for the maintenance of
mature splenic B cells [9], it is not the only requirement.
The splenic microenvironment also plays an essential
role in the maintenance of mature B cells [17]. However,
knowledge regarding the nature and regulation of the
splenic microenvironment is limited, particularly as it
pertains to the accumulation and maintenance of splenic
lymphocytes. Our work suggests that AUF1 is important
in the regulation of survival signals needed for the main-
tenance of FO B cells within the spleen, as indicated by
decreased Bcl-2, A1, and Bcl-XL levels. Spleens from
AUF1
-/- mice bear a strong resemblance to those of Bcl-
2 - d e f i c i e n tm i c ei nt h a tt h e ya r es m a l l e r ,s h o wal o s so f
mature B and T cells, and show many apoptotic cells
[32]. Mature recirculating IgM
loIgD
hi FO B cells from
lymph nodes of AUF1
-/- mice exhibit no significant dif-
ferences in Bcl-2 expression (see Additional file 1), sug-
gesting that the survival signal provided in lymph nodes
is unaffected by the absence of AUF1. These findings
highlight differences in survival signals necessary for
recirculating mature B cells in different lymphoid
organs. In support of this hypothesis, it has been
recently shown that macrophage migration inhibitory
factor (MIF), through the activation of the CD74-CD44
complex, is necessary in the maintenance of mature B
cells in the bone marrow, but not in the spleen or
lymph nodes [48]. The spleen-specific alterations in
lymphocyte populations in AUF1
-/- mice suggests that
AUF1 acts in regulating the local microenvironment, as
opposed to regulating global factors in lymphocyte
development, such as BCR signaling that appears normal
in AUF1
-/- B lymphocytes. Future studies with a more
comprehensive screening approach, such as cDNA
micro-arrays, may prove valuable in identifying mRNAs
regulated by AUF1 that play a role in FO B cell lympho-
cyte survival within the spleen. CD40 engagement on
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2 family members, which protect these cells from anti-
gen receptor-mediated apoptosis [33] and are required
for GC formation, progression [49] and TD response
[50]. AUF1
-/- FO B cells were able to appropriately
induce the expression of Bcl-2 and A1 in response to
CD40 engagement, which supports their ability to form
germinal centers in AUF1-deficient mice.
An important phenotype of AUF1-deficiency is a
decrease in the number of splenic lymphocytes and a
skewing of the B cell subpopulations, with an over-repre-
sentation of immature and MZ B cells and a decrease in
FO B cells. There are several possible mechanisms that
may account for this complex phenotype. AUF1 may regu-
late a survival signal needed for the maintenance of FO B
cells, the largest component of splenic B cells, and loss of
this population could lead to a decrease in the accumula-
tion of T cells within the spleen. Previous studies on B
cell-deficient mice have reported a decrease in splenic T
cell numbers [30,51]. BCR-deficient mice exhibit a three-
fold reduction in the number of splenic CD4 and CD8 T
cells, although no loss of T cells was seen in lymph nodes
from these animals [30]. These results suggest that B cells
provide signals that promote CD4 and CD8 T cell accu-
mulation and/or survival in the spleen [30]. Notably,
CD3ε- and CD4-deficient mice show a 40% reduction of
splenic mature B cells, suggesting that T cells may also
impact the survival of B cells within the spleen [31]. Like-
wise, AUF1 may regulate survival signals required inde-
pendently for the maintenance of FO B and T cells. At
this time we cannot distinguish whether the loss of T and
B cells within the spleen are related, or whether both
populations, independent of each other, are deficient in
survival signals, resulting in decreased Bcl-2 expression in
both populations in AUF1
-/- mice (see Additional file 1).
These mechanisms predict that the 50% decrease in sple-
nic B cells in AUF1
-/- mice results from increased FO B
cell turnover that outpaces the rate of FO B cell produc-
tion by two-fold. However, BrdU studies indicate that
there is a 2.1-fold decrease in splenic FO B cell average
h a l f - l i f ea n da1 . 7 - f o l di n c r e a s eo fBc e l lp r o d u c t i o ni n
AUF1
-/- mice. This would result in a 30% decrease in FO
B cells and not the 50% decrease observed in AUF1
-/-
mice. Furthermore, if turnover did outpace production by
two-fold, one would predict a greater decrease than the
20% seen in recirculating mature B cells in lymph nodes
and bone marrow of AUF1
-/- mice.
The data from bone marrow adoptive transfer studies
more likely indicate that two separate processes are
involved in the observed phenotype: (1) AUF1 is impor-
tant in the maintenance of FO B cells within the spleen,
most likely through regulation of survival factors; and
(2) AUF1 impacts the number of lymphocytes within
the spleen through the regulation of yet unknown
signals. Adoptive transfer studies support the involve-
ment of two separate processes, as reconstitution of irra-
diated AUF1
-/- mice with wild-type bone marrow
corrects the shifts in B cell subpopulation proportions
but not the overall number of splenocytes. The involve-
ment of two separate processes also better explains the
deficit in FO B cells. The 40% decrease in the number
of splenocytes, in addition to the increased FO B cell
turnover that would result in a 30% decrease in the pro-
portion of FO B cells, more accurately approximates the
50% decrease in the number of FO B cells observed in
AUF1
-/- mice.
The complex phenotype seen in AUF1-deficient mice is
not surprising, given that AUF1 regulates the expression
of numerous immune-modulating cytokines and chemo-
kines [20,36,52,53]. Although we have focused here on
defects in the B cell compartment in AUF1-deficient
mice, we have previously shown defects in the T cell and
macrophage compartments [36]. Moreover, despite the
fact that the FDC network can be visualized, we cannot
exclude that the dendritic subset may be affected in
AUF1-deficient mice and may impact the function, size,
and location of other immune cell compartments. Triste-
traprolin, another ARE-binding protein, binds and regu-
lates the expression of mRNAs encoding key regulators
of human dendritic cell maturation [54]. Future analysis
of specific targets of AUF1 in different immune cell sub-
sets will be important in dissecting the role of AUF1 on
individual populations leading to the overall complex
phenotype seen in its deficiency in the mouse model.
Conclusion
This work demonstrates that AUF1 is important in
determining the size of the splenic lymphocyte popula-
tion and proper survival of FO B cells within the spleen.
Future studies will address the identification and regula-
tion of AUF1 targets as they pertain to splenic size, FO
B cell maintenance, and humoral immune response.
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